EU Endorses New Measures to Protect Women From Valproate Epilepsy Drug EU Endorses New Measures to Protect Women From Valproate Epilepsy Drug
French regulator ANSM said epilepsy drug valproate would face new restrictions across the European Union to protect pregnant women or of child-bearing age from exposing their babies to possible malformations and developmental problems.Reuters Health Information
Now doctors call for misoprostol to be allowed for home use across the UK Related items fromOnMedica MHRA tightens licence restrictions on valproate for women Hunt announces Medicines and Medical Devices Safety Review Most CCGs missing smoking target for pregnant women Emergency contraception not weight dependent, says MHRA Epilepsy does not affect chance of pregnancy, or outcomes
It ’s expensive, there’s no guarantee of success, and it has side effects Related items fromOnMedica Epilepsy does not affect chance of pregnancy, or outcomes Blood test identifies high-risk lupus pregnancies Tackling obesity ‘must be made a national priority’ Women ’s health czar needed to lead on radical overhaul Contraceptive implants linked with repeat abortions
(MedPage Today) -- Not using folic acid before and during pregnancy increased risks substantially
Credit: New York Times article, Jan. 19, 2016. The United States is in the midst of an opioid overdose epidemic. The rates of opioid addiction, babies born addicted to opioids, and overdoses have skyrocketed in the past decade. No population has been hit harder than rural communities. Many of these communities are in states with historically low levels of funding from the National Institutes of Health (NIH). NIGMS’ Institutional Development Award (IDeA) program builds research capacities in these states by supporting basic, clinical, and translational research, as well as faculty development and infrastructure impro...
WEDNESDAY, Aug. 1, 2018 -- Drugs taken in pregnancy to prevent epilepsy seizures can raise the risk of language delays in children. But new research shows that folic acid supplements can cut that risk. One U.S. ob/gyn said the finding has real...
We report the case of a 34-year-old pregnant woman at the 25th weeks of amenorrhea, who presented a super-refractory epileptic-status due to a right schizencephaly. The diagnosis of eclampsia was excluded. This case report is very particular cause of the late appearance of epileptic seizures in this pregnant woman who has never done so.
In conclusion, these findings support the current understanding that LEV may be a feasible option for PWWE.
CONCLUSIONS: The use of population registers allows a better knowledge of cerebral palsy as well as the evaluation and development of prevention strategies and optimization of care resources with objective data. It is necessary to generalize the use of this type of records in our environment. PMID: 30047119 [PubMed - in process]
Abstract Depot medications have been used for long-term treatment of many different medical conditions (schizophrenia, opioid addiction) and for prevention of pregnancy (birth control). In addition, proposals for depot medication for antidepressants have been made as a possible treatment for chronic depression. For the treatment of chronic epilepsy, there are currently no depot antiepileptic drugs (AEDs). However, there may be a role for them. Depot AEDs could improve medication adherence rates, thereby reducing the morbidity and mortality that are associated with ongoing seizures. This could help to reduce hospit...
Conclusion: Americans' view of marijuana use is more favorable than existing evidence supports. Primary Funding Source: National Heart, Lung, and Blood Institute. PMID: 30039154 [PubMed - as supplied by publisher]